Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
1,954 results
  • Anticoagulation Management during Extracorporeal Membrane Oxygenation-A Mini-Review. [Review]
    Medicina (Kaunas). 2022 Dec 03; 58(12)Burša F, Sklienka P, … Máca J
  • Extracorporeal membrane oxygenation (ECMO) has been established as a life-saving technique for patients with the most severe forms of respiratory or cardiac failure. It can, however, be associated with severe complications. Anticoagulation therapy is required to prevent ECMO circuit thrombosis. It is, however, associated with an increased risk of hemocoagulation disorders. Thus, safe anticoagulat…
  • Cost-effectiveness of bivalirudin in pediatric ventricular assist devices. [Journal Article]
    J Heart Lung Transplant. 2022 Oct 12 [Online ahead of print]Burstein D, Kimmel S, … Conway J
  • CONCLUSIONS: Bivalirudin use significantly increased over the past decade and is now used in 90% young pediatric VAD recipients. Bivalirudin was associated with significantly lower hospital mortality and an ICER <$65,000, making it a cost-effective therapy for pediatric VAD recipients.
  • Comparison of Bivalirudin Versus Heparin for Anticoagulation During Extracorporeal Membrane Oxygenation. [Journal Article]
    ASAIO J. 2022 Oct 04 [Online ahead of print]Hasegawa D, Sato R, … Im Lee Y
  • The effect and safety of bivalirudin compared with heparin in patients undergoing extracorporeal membrane oxygenation (ECMO) remains unclear. Therefore, we conducted a systematic review and meta-analysis to compare the effectiveness and safety of heparin and bivalirudin in patients who underwent ECMO. We searched Embase, the Cochrane Central Register of Controlled Trials, and MEDLINE. Inclusion c…
  • StatPearls: Bivalirudin [BOOK]
    StatPearls. StatPearls Publishing: Treasure Island (FL)BerliozBeric E.BEMayo ClinicSanghaviDevangDMayo ClinicBOOK
  • Bivalirudin is a medication used to manage and treat patients undergoing percutaneous coronary intervention for acute myocardial infarction. It is in the direct thrombin inhibitor class of drugs. This activity reviews the indications, action, and contraindications for bivalirudin as a valuable agent in the therapy of acute myocardial infarction, in addition to its broader applications in thromboe…
New Search Next